Analyst Ratings for MapLight Therapeutics (MPLT)
MPLT Rating Summary
MPLT Price Target Summary
- Highest: $43.00 (Needham)
- Lowest: $13.00 (UBS)
- Average: $29.33
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$29.33 (+281%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 78%
Avg. $ Target:
$29.33 (+281%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 78%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/5/2026 | Guggenheim | Delma Caiati | New Coverage | Neutral (N/A) |
N/A (N/A) |
9.82 (7.70) |
-21.59% | Details |
| 8/10/2026 | UBS | Ashwani Verma | Downgrade | Neutral (Buy) |
13.00 (N/A) |
12.17 (7.70) |
-36.73% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
